🟢 Intravenous Infusions is trading 6.98% up today after recent declines

Intravenous Infusions is trading at GHS 0.46, up 6.98%, rebounding after several sessions of declines following July’s speculative rally.

• No clear company-specific announcement explaining the August 18, 2026 move was identified.
• Earlier August coverage linked the selloff to profit-taking; profitability and board news predated this session.
• The broader U.S. market is weaker, so global sentiment does not clearly explain the gain.